Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of azilsartan medoxomil,
once daily (QD), compared to placebo and olmesartan in participants with essential
hypertension.